HuGE Literature Finder
Records
1
-
2
c-MET/VEGFR-2 co-localisation impacts on survival following bevacizumab therapy in epithelial ovarian cancer: an exploratory biomarker study of the phase 3 ICON7 trial. BMC medicine 2022 Feb 20 (1): 59. Morgan Robert D, Ferreras Cristina, Peset Isabel, Avizienyte Egle, Renehan Andrew G, Edmondson Richard J, Murphy Alexander D, Nicum Shibani, Van Brussel Thomas, Clamp Andrew R, Lambrechts Diether, Zhou Cong, Jayson Gordon |
Carboplatin/taxane-induced gastrointestinal toxicity: a pharmacogenomics study on the SCOTROC1 trial. The pharmacogenomics journal 2015 Jul . He Y J, Winham S J, Hoskins J M, Glass S, Paul J, Brown R, Motsinger-Reif A, McLeod H |
- Page last reviewed:Jul 25, 2022
- Page last updated:Aug 03, 2022
- Content source: